The short version of bremelanotide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-03. Anything still debated is marked as such rather than presented as settled.
Compared with melanotan II, bremelanotide is a smaller cyclic peptide with a more constrained backbone, which affects receptor selectivity and metabolic stability. Published descriptions give a plasma half-life on the order of a few hours after subcutaneous administration, with elimination through hepatic and renal routes and limited plasma protein binding. Central access is inferred from effects observed in animal models, although direct measurement in humans is limited. Handling and storage requirements follow from the peptide backbone, which is susceptible to hydrolysis and oxidation.
The melanocortin system comprises five G protein-coupled receptors, designated MC1 through MC5, that signal mainly through cyclic AMP accumulation. MC1R and MC2R are associated with pigmentation and adrenal steroid production, while MC3R and MC4R are expressed in the central nervous system and influence energy balance and behavior. MC5R appears in exocrine tissues. Natural agonists include alpha-melanocyte-stimulating hormone and adrenocorticotropic hormone, and endogenous antagonists such as agouti-related protein modulate the same sites. This receptor family provides the framework within which bremelanotide activity is described.
Bremelanotide acts as an agonist at several melanocortin receptors, with the strongest reported activity at MC4R and measurable activity at MC1R and MC3R. Because MC4R is expressed in hypothalamic and limbic circuits, the proposed mechanism links receptor activation to modulation of central pathways involved in desire rather than to direct effects on peripheral genital tissue. The precise downstream steps remain incompletely characterized, and evidence for the involvement of specific neurotransmitters is suggestive rather than settled. Nausea and blood pressure elevation reported during trials are consistent with melanocortin signaling outside the intended target circuit.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Published studies differ in design, population and endpoint definition, so results are not always directly comparable across reports. Some trials used patient-reported measures of desire and distress, while others tracked physiological or behavioural outcomes. Questions that remain open include the durability of effects beyond short follow-up periods, the frequency of transient blood pressure elevation observed after administration, and whether a subtype-selective analogue could separate central effects from pigmentation-related activity. These points are usually framed as unresolved rather than settled in review literature.
| Property | Value | Notes |
|---|---|---|
| Primary receptor target | MC4R | Highest reported agonist potency within the family |
| Secondary receptor activity | MC1R and MC3R | Lower potency than at MC4R |
| Elimination half-life | About 2 to 3 hours | Measured after subcutaneous administration |
| Plasma protein binding | Approximately 44 percent | Species- and assay-dependent |
| Route of administration | Subcutaneous injection | Reviewed product uses a single-use device |
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
These imperatores (lit: victorious generals, from the title imperator they were hailed with by their troops) frequently fell out with each other and started civil wars to seize control of the state, such as Sulla, Caesar, Pompey, Crassus, Mark Antony and Octavian (later Augustus, the first Emperor himself). In this context, the imperatores raised many legions that were not authorised by the Senate, sometimes having to use their own resources. As civil wars were resolved, many of these "private" units would be disbanded, only for more to be raised to fight the next civil war. By the time Augustus emerged as sole ruler of Rome in 31 BC, over 50 legions were in existence, many of which were disbanded. The legions included in the following list had a long enough history to be somehow remarkable. Most of them were levied by Julius Caesar and later included into Octavian's army, some of them were levied by Mark Antony.
=== Viral assembly === Genetically engineered M13 bacteriophage viruses allow preparation of quantum dot biocomposite structures. It had previously been shown that genetically engineered viruses can recognize specific semiconductor surfaces through the method of selection by combinatorial phage display. Additionally, it is known that liquid crystalline structures of wild-type viruses (Fd, M13, and TMV) are adjustable by controlling the solution concentrations, solution ionic strength, and the external magnetic field applied to the solutions. Consequently, the specific recognition properties of the virus can be used to organize inorganic nanocrystals, forming ordered arrays over the length scale defined by liquid crystal formation. Using this information, Lee et al. (2000) were able to create self-assembled, highly oriented, self-supporting films from a phage and ZnS precursor solution. This system allowed them to vary both the length of bacteriophage and the type of inorganic material through genetic modification and selection.
Competence stimulating peptides are a subset of proteins that promote quorum sensing in numerous bacterial genera including Streptococcus and Bacillus. Quorum sensing contributes to regulation of specific gene expressions in response to cell population density fluctuations. Streptococcus pneumonia, a highly studied gram-positive bacterium, is capable of quorum sensing and can release autoinducers, chemical signals that increase as concentration based on density. CSPs are part of a unique form of regulation involved in DNA processing. The form of DNA processing starts abruptly and at the same time in all cells when in a constantly or exponentially growing culture, and then growth rapidly decreases after about 12 minutes of exponential growth.
Some species of fungi live most of their life cycles as molds in soil, but upon entering a host animal, they transition to a yeast form, along with expression of virulence factors that convert them into effective and dangerous pathogens. These are known as dimorphic fungi and are typically capable of reproduction in the typical yeast fashion, including via budding. In these organisms, the yeast form transition is required for pathogenicity; if the transition is stopped somehow, the mold form does not cause disease. The rounded and separated forms of yeasts help them to spread through the bloodstream to organ systems. In some infections caused by dimorphic fungi, such as emergomycosis, respiratory symptoms are uncommon, even though the fungus initially enters through the lungs. Most molds are not dimorphic, and only a very small number of species cause dimorphic fungal disease in humans.
Sources: en.wikipedia.org
=== Awards === The Orange Box won a number of awards for its overall high standard and use of technology. The compilation won "Computer Game of the Year" at the Academy of Interactive Arts & Sciences' 11th Annual Interactive Achievement Awards; it also received nominations in the "Overall Game of the Year", "Action Game of the Year", and "Outstanding Innovation in Gaming" categories. The Orange Box won the "Breakthrough Technology Award" and the "Best PC Game Award" at the 2007 Spike Video Game Awards, and was additionally nominated in the "Game of the Year", "Best Shooter", "Best Xbox 360 Game", and "Best Multiplayer Game" categories. It was also named the second-best video game of 2007 by Time Magazine, while the PlayStation 3 version was nominated in the category of Action and Adventure at the BAFTA Video Games Awards. Valve also received developer awards for their work on The Orange Box. The Orange Box received 17 Game of the Year awards and over 100 awards in total. The Orange Box was placed as the 22nd most influential video game in history by the Guinness World Records Gamer's Edition, 2009. Portal won "Outstanding Achievement in Game Design", "Outstanding Achievement in Gameplay Engineering", and "Outstanding Character Performance" for Ellen McLain's vocal portrayal of GLaDOS at the 11th Annual Interactive Achievement Awards. The game won 76 awards, including 37 Game of the Year awards, and was recognized for innovative design and game mechanics. The dark humor of Portal and the ending music track "Still Alive" were also singled out for awards.
=== Source attribution and forensics === Stable isotope ratios have found uses in various instances where the authenticity or origin of a chemical compound is called into question. Such situations include assessing the authenticity of food, wine and natural flavors; drug screening in sports (see doping in sport); pharmaceuticals; illicit drugs; and even helping identify human remains. In these cases it is often not enough to detect or quantify a certain compound, since the question is the origin of the compound. The strength of hydrogen isotope analysis in answering these questions is that the DHR of a natural product is often related to the natural water DHRs in the area where the product was formed (see: Hydrologic cycle). Since DHRs vary significantly between different areas, this can be a powerful tool in locating the original source of many different substance.
== Mechanism == Uniporters work to transport molecules or ions by passive transport across a cell membrane down its concentration gradient. Upon binding and recognition of a specific substrate molecule on one side of the uniporter membrane, a conformational change is triggered in the transporter protein. This causes the transporter protein to change its three-dimensional shape, which ensures the substrate molecule is captured within the transporter proteins structure. The conformational change leads to the translocation of the substrate across the membrane onto the other side. On the other side of the membrane, the uniporter undergoes another conformational change in the release of the substrate molecule. The uniporter returns to its original conformation to bind another molecule for transport. Unlike symporters and antiporters, uniporters transport one molecule/ion in a single direction based on the concentration gradient. The entire process depends on the substrate's concentration difference across the membrane to be the driving force for the transport by uniporters. Cellular energy in the form of ATP is not required for this process.
Sources: en.wikipedia.org
Reported activity is highest at MC4R, with lower potency at MC1R and MC3R. The MC4R interaction is generally treated as the most relevant to its central effects. Selectivity is not absolute, and activity across the family is dose-dependent.
Indirect evidence from animal studies supports central access, and the proposed mechanism requires it. Direct quantification in humans is limited. How much reaches specific brain regions remains an open question.
Published descriptions give a plasma half-life of roughly two to three hours after subcutaneous administration. Values vary with assay method and study population. The figure is an average rather than a fixed molecular property.
The peptide is polar and charged, and reversed-phase chromatography with acidic mobile phases resolves it well from related substances. Ultraviolet detection near 214 nm gives adequate sensitivity without derivatisation.